Latest Articles

Publication Date
Molecular subtype of recurrent implantation failure reveals distinct endometrial etiology of female infertility - Journal of Translational Medicine

Molecular subtype of recurrent implantation failure reveals distinct endometrial etiology of female infertility Journal of Translational Medicine

Published: July 14, 2025, 11:45 a.m.
Advanced Ovarian and Endometrial Cancers Respond to Combination Immunotherapy - Labroots

Advanced Ovarian and Endometrial Cancers Respond to Combination Immunotherapy Labroots

Published: July 14, 2025, 10 a.m.
Kadriye Baskurt: Grateful to Have Joined the ESMO Endometrial Cancer Preceptorship in Lugano - Oncodaily

Kadriye Baskurt: Grateful to Have Joined the ESMO Endometrial Cancer Preceptorship in Lugano Oncodaily

Published: July 12, 2025, 8 p.m.
MicroRNA participates in embryo implantation by modulating endometrial tolerance in sows during peri-implantation period - Frontiers

MicroRNA participates in embryo implantation by modulating endometrial tolerance in sows during peri-implantation period Frontiers

Published: July 11, 2025, 8:08 p.m.
Dostarlimab Plus Chemo Prolongs Time to First, Second Subsequent Therapy Regardless of Age in Endometrial Cancer - OncLive

Dostarlimab Plus Chemo Prolongs Time to First, Second Subsequent Therapy Regardless of Age in Endometrial Cancer OncLive

Published: July 11, 2025, 6:17 p.m.
BioNTech’s Promising Phase III Trial for Recurrent Endometrial Cancer - TipRanks

BioNTech’s Promising Phase III Trial for Recurrent Endometrial Cancer TipRanks

Published: July 11, 2025, 4:24 p.m.
Clinical Pregnancy Outcomes in Young Women with Diminished Ovarian Reserve Undergoing Frozen Embryo Transfer: A Comprehensive Analysis with Exploratory Insights into Endometrial Aging - Frontiers

Clinical Pregnancy Outcomes in Young Women with Diminished Ovarian Reserve Undergoing Frozen Embryo Transfer: A Comprehensive Analysis with Exploratory Insights into Endometrial Aging Frontiers

Published: July 10, 2025, 7:26 p.m.
Sussex Cancer Fund supports ground-breaking study into the impact of stress on endometrial cancer - MSN

Sussex Cancer Fund supports ground-breaking study into the impact of stress on endometrial cancer MSN

Published: July 9, 2025, 11:31 p.m.
XBP1 promoted EMT and fibrosis in endometrial epithelial cells. (a)... - researchgate.net

XBP1 promoted EMT and fibrosis in endometrial epithelial cells. (a)... researchgate.net

Published: July 9, 2025, 7:31 p.m.
BioNTech’s Phase III Trial: A Potential Game-Changer in Endometrial Cancer Treatment - TipRanks

BioNTech’s Phase III Trial: A Potential Game-Changer in Endometrial Cancer Treatment TipRanks

Published: July 9, 2025, 4:04 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!